Literature DB >> 22119888

Nucleofection-based gene targeting in human pre-B cells.

Aya Kurosawa1, Shinta Saito, Mikako Mori, Noritaka Adachi.   

Abstract

Electroporation is a powerful and convenient means for transfection of nonviral vectors into mammalian cells, providing an essential tool for numerous applications including gene targeting via homologous recombination. Recent evidence clearly suggests that high-efficiency gene transfer can be achieved in most cell lines by nucleofection, an electroporation-based transfection method that allows transfected vectors to directly enter the nucleus. In this paper, we analyze the effectiveness of nucleofection for gene targeting using human pre-B cells. For this, we tested 93 different transfection conditions, and found several conditions that gave high (~80%) transfection efficiency with low cytotoxicity (~70% survival rate). Remarkably, under the optimal nucleofection conditions, the gene-targeting efficiency was ~2-5-fold higher than that achieved with conventional electroporation methods. We also found that nucleofection conditions with high transfection efficiency and low cytotoxicity tend to provide high gene-targeting efficiency. Our results provide significant implications for gene targeting, and suggest that nucleofection-based nonviral gene transfer is useful for systematic generation of human gene-knockout cell lines.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22119888     DOI: 10.1016/j.gene.2011.11.003

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  3 in total

1.  mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end.

Authors:  Wei Su; Sergey V Slepenkov; Michael K Slevin; Shawn M Lyons; Marcin Ziemniak; Joanna Kowalska; Edward Darzynkiewicz; Jacek Jemielity; William F Marzluff; Robert E Rhoads
Journal:  RNA       Date:  2012-11-27       Impact factor: 4.942

2.  RNAi Transfection Optimized in Primary Naïve B Cells for the Targeted Analysis of Human Plasma Cell Differentiation.

Authors:  Tiffany Shih; Saurav De; Betsy J Barnes
Journal:  Front Immunol       Date:  2019-07-23       Impact factor: 7.561

3.  All-in-one processing of heterogeneous human cell grafts for gene and cell therapy.

Authors:  Ekaterina Y Lukianova-Hleb; Eric S Yvon; Elizabeth J Shpall; Dmitri O Lapotko
Journal:  Mol Ther Methods Clin Dev       Date:  2016-03-16       Impact factor: 6.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.